Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
November 21, 2017
Vermillion to Present at the 29th Annual Piper Jaffray Healthcare Conference
AUSTIN, Texas, Nov. 21, 2017 /PRNewswire/ -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that Valerie Palmieri, President and Chief ...
November 21, 2017
Molecular Templates to Present at the 29th Annual Piper Jaffray Healthcare Conference
AUSTIN, Texas, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered ...
November 20, 2017
Kamada and Chiesi Farmaceutici S.p.A. Mutually Agree to Terminate European Distribution Agreement for Inhaled Alpha-1 Antitrypsin Therapy for Treatment of Alpha-1 Antitrypsin Deficiency
REHOVOT, Israel, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd. (KMDA) (KMDA), a plasma-derived protein therapeutics company focused on orphan indications, today announced that the ...
November 20, 2017
Aimmune Therapeutics to Host Investor Symposium on Peanut Allergy Treatment with Leading Expert Allergists on Friday, December 1
BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that it will host an Investor Symposium in ...
November 20, 2017
CorMedix Inc. Announces Common Stock Purchase by Company Directors and Executive Management Team
BERKELEY HEIGHTS, NJ / ACCESSWIRE / November 20, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
November 20, 2017
ASPiRA Labs Announces Release of Final CMS Reimbursement Rate for OVA1
AUSTIN, Texas, Nov. 20, 2017 /PRNewswire/ -- ASPiRA Labs, a Vermillion company (VRML) and the exclusive distributor of OVA1 (Multivariate Index Assay) (MIA), and Overa (MIA2G), ...
November 20, 2017
Brainsway Reports Record Quarterly Revenues in Third Quarter of 2017
HACKENSACK, N.J., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, today announced the Company’s ...
November 17, 2017
U.S. FDA Extends Review for TLANDO™; Advisory Committee Meeting Date of January 10, 2018 Remains Unchanged
SALT LAKE CITY, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, today announced the U.S. Food and Drug Administration (“FDA”) ...
November 17, 2017
VBL Therapeutics Prices 2.5 Million Ordinary Share Offering
TEL AVIV, Israel, Nov. 17, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
November 16, 2017
Spring Bank Pharmaceuticals Announces Positive Top-Line Results from the Second Cohort of Part A of the Phase 2 ACHIEVE Trial
HOPKINTON, Mass., Nov. 15, 2017 (GLOBE NEWSWIRE) --  Spring Bank Pharmaceuticals, Inc. (SBPH) today announced top-line results from the second cohort (50mg monotherapy) of Part ...
November 16, 2017
Arcturus Therapeutics Announces Completion of Merger with Alcobra Ltd. and Commences Trading on the Nasdaq Global Market
SAN DIEGO, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (Nasdaq:ARCT), a leading RNA medicines company, announced today the completion of its previously announced ...
November 16, 2017
MediWound Reports Third Quarter 2017 Financial Results
YAVNE, Israel, Nov. 16, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
November 16, 2017
Prothena Highlights Breadth of Novel Pipeline at R&D Day
DUBLIN, Ireland, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of ...
November 16, 2017
Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors
MORRISTOWN, N.J., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced the election ...
November 16, 2017
Vermillion Announces Publication of Foundational Health Economics Study
AUSTIN, Texas, Nov. 16, 2017 /PRNewswire/ -- Vermillion (VRML) announced today the acceptance and publication of a novel paper, "Economic Impact of Increased Utilization of ...
November 16, 2017
Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock
SAN DIEGO, Nov. 16, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (MRTX) today announced the pricing of an underwritten public offering of 2,015,901 shares of its common ...
November 15, 2017
INNATE PHARMA : Third quarter 2017 report
Marseille, France, November 15, 2017, 7:00 AM CET -- Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces its revenues and cash ...
November 15, 2017
Foamix Reports Third Quarter 2017 Financial Results and Provides Business Update
REHOVOT, Israel, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX) (“Foamix Pharmaceuticals” or the “Company”), a clinical stage specialty pharmaceutical company focused on ...
November 15, 2017
BioTime Presents Updated OpRegen® Phase I/IIa Trial Data at AAO
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that ...
November 15, 2017
ADMA Biologics Further Enhances Intellectual Property Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Compositions
RAMSEY, N.J. and BOCA RATON, Fla., Nov. 15, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) is a vertically integrated biopharmaceutical and specialty immunoglobulin company ...
Page 97 of 138